⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30539244 | 1.00 | — | — | |
| SCHEMBL1406164 | 1.00 | — | — | |
| SCHEMBL29257457 | 1.00 | — | — | |
| SCHEMBL31282752 | 1.00 | — | — | |
| SCHEMBL3955154 | 1.00 | — | — | |
| SCHEMBL182611 | 1.00 | — | — | |
| SCHEMBL28888586 | 1.00 | — | — | |
| SCHEMBL3957856 | 1.00 | — | — | |
| SCHEMBL19649384 | 1.00 | — | — | |
| SCHEMBL27627588 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161428-A1 | PREVENTING/TREATING PSEUDOMONAS AERUGINOSA INFECTION | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2025-05-22 | — | — | US | disclosed |
| EP-4490181-A1 | PREVENTING/TREATING PSEUDOMONAS AERUGINOSA INFECTION | National Research Council of Canada (CA) | 2025-01-15 | — | — | EP | disclosed |
| CN-119095871-A | Prevention/treatment of pseudomonas aeruginosa infection | 加拿大国家研究委员会 | 2024-12-06 | — | — | CN | disclosed |
| WO-2023168520-A1 | PREVENTING/TREATING PSEUDOMONAS AERUGINOSA INFECTION | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2023-09-14 | — | — | WO | disclosed |